|
Lorna Ewart PhD
Chief Scientific Officer
Emulate
|
Lorna is Chief Scientific Officer at Emulate where she provides strategic guidance and oversight of the scientific vision, leads partnerships with government agencies to achieve regulatory acceptance and collaborates with key customers to advance adoption of organ-on-a-chip technology, a positive disruptor to the drug discovery and development process. Prior to joining Emulate she spent 20 years at AstraZeneca, where she held roles of increasing responsibility including the Director of Toxicology Projects within the respiratory and inflammation research area before she finally successfully established and led the Microphysiological Systems Centre of Excellence within the R&D Biopharmaceuticals Unit. She obtained her honours degree in pharmacology at the University of Aberdeen in Scotland and her PhD at the William Harvey Research Institute in London. Lorna was recently honoured with a Doctorate of Science in recognition of her work in the Organ-Chip field by Queen Mary, University of London and she is a fellow of the Royal Society of Biology and British Pharmacological Society.